Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Selected Issues in Pharmaceutical Drug Pricing (CRS Report for Congress)

Premium   Purchase PDF for $24.95 (3 pages)
add to cart or subscribe for unlimited access
Release Date Revised March 1, 2023
Report Number IF12272
Report Type In Focus
Authors Jim Hahn; Kevin J. Hickey; Suzanne M. Kirchhoff; Hannah-Alise Rogers
Source Agency Congressional Research Service
Older Revisions
  • Premium   Dec. 7, 2022 (2 pages, $24.95) add
Summary:

Many factors influence the prices consumers pay for prescription drugs. Congress has repeatedly attempted to address high drug prices through legislation, including bills that seek to increase generic competition, lower prices for certain health care entities that serve rural and vulnerable populations, and regulate drug price negotiations through the Medicare program. Congress has also proposed to cap out-of-pocket Medicare costs, increase drug price transparency, permit more drug importation, and regulate pharmacy benefit managers. This In Focus reviews several issues affecting drug prices of potential interest to the 118th Congress.